<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27">
 <label>27.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marçais</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Cherfils-Vicini</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Viant</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Degouve</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Viel</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Fenis</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>The metabolic checkpoint kinase mTOR is essential for interleukin-15 signaling during NK cell development and activation</article-title>. 
  <source>Nat Immunol.</source> (
  <year>2014</year>) 
  <volume>15</volume>:
  <fpage>749</fpage>–
  <lpage>57</lpage>. 
  <pub-id pub-id-type="doi">10.1038/ni.2936</pub-id>
  <?supplied-pmid 24973821?>
  <pub-id pub-id-type="pmid">24973821</pub-id>
 </mixed-citation>
</ref>
